The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Milica Momcilovic(University of California, Los Angeles), David B. Shackelford(University of California, Los Angeles), Noah Federman(University of California, Los Angeles), Michael C. Fishbein, Susan D. Demo(Calithera (United States)), Maie A. St. John(University of Colorado Cancer Center), Thomas G. Graeber(Exicure (United States)), Robert Shuman(MemorialCare Health System), Heather R. Christofk(APLA Health), Daniel Braas, Sean T. Bailey(University of California, Los Angeles), Saman Sadeghi(University of California, Los Angeles), Jane Yanagawa(University of California, Los Angeles), Michael Gricowski(MemorialCare Health System), Karam W. Badran(University of California, Los Angeles), Julio A. Ibarra(MemorialCare Health System), Jason T. Lee(University of California, Los Angeles), Deborah Fridman(Hoag Memorial Hospital Presbyterian), Tonya C. Walser(City of Hope), Francesco Parlati(Calithera (United States)), Rui Li(University of California, Los Angeles), Steven M. Dubinett(University of California, Los Angeles), Michael E. Phelps(National Academy of Engineering), James Go(University of California, Los Angeles), Nicholas M. Bernthal(Harvard University)
Cited by 189
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k